REVEAL-CKD: PREVALENCE OF UNDIAGNOSED STAGE 3 CHRONIC KIDNEY DISEASE IN ENGLAND

WCN23-0626
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Chronic Kidney Disease Diagnosis, Classification and Progression
 
 
 
 
REVEAL-CKD: PREVALENCE OF UNDIAGNOSED STAGE 3 CHRONIC KIDNEY DISEASE IN ENGLAND
Kanumilli, N.(1)*;Peach, E.(2);Barone, S.(3);Arnold, M.(4);Tangri, N.(5);
ie: Azwin Z.1, Siti Y.1, John D.2
(1)Northenden Group Practice, Northenden Group Practice, Manchester, United Kingdom;(2)Astrazeneca, Cardiovascular Renal And Metabolism Epidemiology, Cambridge, United Kingdom;(3)Astrazeneca, Global Medical Affairs, Gaithersburg, United States;(4)Astrazeneca, Real World Science And Digital, Cambridge, United Kingdom;(5)University Of Manitoba, Department Of Internal Medicine, Winnipeg, Canada;
https://storage.unitedwebnetwork.com/files/1041/8409ded6ed11531bdf0ab16c20acf7c2.pdf
https://storage.unitedwebnetwork.com/files/1041/57a794755f58bbb5d1e5c0e9e77b3d30.mp3
if any